Response to: 'Should patients starting biologics be screened for COVID-19?' by Cardenas-de la Garza et al

Robert B. M. Landewé, Hendrik Schulze-Koops

Research output: Contribution to journalLetterAcademicpeer-review

Original languageEnglish
Article numberannrheumdis-2020-218470
JournalAnnals of the rheumatic diseases
Early online date2020
DOIs
Publication statusPublished - 22 Jul 2020

Keywords

  • epidemiology
  • health services research
  • patient care team
  • quality indicators, health care

Cite this